Related Experiment Video
Updated: Jun 16, 2025
An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
Evolving FATE: A New Lens on the Pathogenesis and Management of Feline Cardiogenic Arterial Thromboembolism
Natasha S Yeh1, Meg Shaverdian2, Ronald H L Li3
1Terry Veterinary Medical Center, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA.
Insights
Feline cardiogenic arterial thromboembolism (FATE) is a severe complication of heart disease in cats. This review explores FATE
Area of Science:
- Veterinary Cardiology
- Thrombosis Research
- Feline Medicine
Background:
- Feline cardiogenic arterial thromboembolism (FATE) is a critical complication of feline cardiomyopathies.
- High mortality and recurrence rates underscore the clinical significance of FATE.
- Existing knowledge gaps hinder effective management and treatment strategies.
Purpose of the Study:
- To provide a comprehensive review of feline cardiogenic arterial thromboembolism (FATE).
- To address knowledge gaps in FATE pathogenesis and management.
- To identify future research directions for improved feline patient outcomes.
Main Methods:
- Literature review of current scientific understanding of FATE.
- Analysis of disease mechanisms, risk factors, diagnostics, and prevention.
- Identification of emerging research areas relevant to FATE.
Main Results:
- FATE is a significant complication of feline cardiomyopathies.
- Key areas for future research include immunothrombosis, platelet function, and fibrinolysis.
- Novel biomarkers and therapeutic targets are needed to improve FATE outcomes.
Conclusions:
- Further research into specific mechanisms like immunothrombosis and platelet activity is crucial.
- Developing new diagnostic and therapeutic strategies for FATE is essential.
- Improving understanding of FATE pathogenesis will enhance feline patient care.
Abstract:
Feline cardiogenic arterial thromboembolism (FATE) remains one of the most devastating complications of feline cardiomyopathies, with high mortality and recurrence rates. Despite its clinical importance, significant knowledge gaps persist in our understanding of FATE's pathogenesis and optimal management strategies. Our review aims to address these gaps by providing a comprehensive overview of the current understanding of FATE, including disease mechanisms, risk factors, emerging diagnostics, and preventative strategies. Importantly, we identify key areas such as immunothrombosis, procoagulant platelets, platelet heterogeneity, and altered fibrinolysis where future research may yield novel biomarkers and therapeutic targets to improve outcomes in affected feline patients.
